- Home
- APM vs AURE Comparison
APM vs AURE Comparison
Compare APM & AURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APM
- AURE
- Stock Information
- Founded
- APM 2010
- AURE 2018
- Country
- APM United Kingdom
- AURE Hong Kong
- Employees
- APM N/A
- AURE N/A
- Industry
- APM Biotechnology: Pharmaceutical Preparations
- AURE Finance: Consumer Services
- Sector
- APM Health Care
- AURE Finance
- Exchange
- APM Nasdaq
- AURE Nasdaq
- Market Cap
- APM 18.9M
- AURE 19.4M
- IPO Year
- APM 2018
- AURE N/A
- Fundamental
- Price
- APM $1.39
- AURE $0.40
- Analyst Decision
- APM
- AURE
- Analyst Count
- APM 0
- AURE 0
- Target Price
- APM N/A
- AURE N/A
- AVG Volume (30 Days)
- APM 113.6K
- AURE 505.0K
- Earning Date
- APM 12-19-2025
- AURE 02-13-2026
- Dividend Yield
- APM N/A
- AURE N/A
- EPS Growth
- APM N/A
- AURE N/A
- EPS
- APM N/A
- AURE N/A
- Revenue
- APM N/A
- AURE $142,570.00
- Revenue This Year
- APM N/A
- AURE N/A
- Revenue Next Year
- APM N/A
- AURE N/A
- P/E Ratio
- APM N/A
- AURE N/A
- Revenue Growth
- APM N/A
- AURE N/A
- 52 Week Low
- APM $0.46
- AURE $0.31
- 52 Week High
- APM $7.49
- AURE $2.70
- Technical
- Relative Strength Index (RSI)
- APM 35.35
- AURE N/A
- Support Level
- APM $1.43
- AURE N/A
- Resistance Level
- APM $1.43
- AURE N/A
- Average True Range (ATR)
- APM 0.08
- AURE 0.00
- MACD
- APM -0.01
- AURE 0.00
- Stochastic Oscillator
- APM 9.27
- AURE 0.00
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.